Biological Products, (No Diagnostic Substances) · NY · CIK 1681087
Tectonic Therapeutic discovers and develops biologic medicines targeting GPCRs for unmet medical needs
Comparable business profile · signals at a glance
In the 90 days to Mar 6, 2026: 2 insiders bought $235K · 2 sold $567K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 6, 2026 | Ruddy Marcella K.Chief Medical Officer | Sell | 10,000 | $30.00 | $300K |
| Mar 6, 2026 | Mcnamara PeterChief Scientific Officer | Sell | 6,047 | $30.00 | $181K |
| Mar 6, 2026 | Mcnamara PeterChief Scientific Officer | Sell | 215 | $35.00 | $8K |
| Mar 4, 2026 | Mcnamara PeterChief Scientific Officer | Sell | 1,650 | $25.00 | $41K |
| Mar 3, 2026 | Mcnamara PeterChief Scientific Officer | Sell | 1,649 | $22.06 | $36K |
| Feb 11, 2026 | Reicin AliseChief Executive Officer | Buy | 2,500 | $21.10 | $53K |
| Feb 11, 2026 | Reicin AliseChief Executive Officer | Buy | 2,500 | $21.10 | $53K |
| Feb 10, 2026 | Lochner DanielChief Financial Officer | Buy | 6,000 | $21.61 | $130K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.